admin Aging, something which is considered to be inevitable in life, has gone through a dynamic shift in recent times. Introducing Elizabeth Parrish, or popularly known as Liz Parrish has changed the dynamics of aging. Because of her, people have started believing in gene therapy as before this concept, aging was considered as inevitable and untreatable and at cellular level, aging manifests as the accrual of various forms of molecular damage, collectively referred to as the hallmarks of aging, which accumulate over time, leading to a decline in physiological function and an increased susceptibility to age-related diseases.
Although, in recent years, gene therapy has come up as a promising frontier in order to combat aging and promote longevity. Gene therapy involves the delivery of genetic material into cells to correct or modulate gene expression, and has demonstrated remarkable efficacy in reversing age-related processes in experimental models. By targeting key pathways implicated in aging, gene therapy holds the potential to rejuvenate tissues, enhance resilience to stressors, and extend healthspan—the period of life free from chronic disease and disability.
About BioViva USA Inc.
“We will ‘de-age’ progressively, as cures are developed.”
– Liz Parrish, CEO
Founded in the year 2015 by Elizabeth Parrish, BioViva is committed to advancing human longevity through innovative genetic interventions. By focusing on developing cutting-edge gene therapies, the main goal is to completely transform healthcare and empower individuals to lead a better and longer life.
Liz Parrish, the pioneer and backbone of this company, has been an expert of genetic medicine and an advocate for gender accessibility for transformative treatments. She was motivated by her personal experience, as her son was diagnosed with Type 1 diabetes. Coming from such a background, she commenced a journey to accelerate the development and dissemination of gene therapies for aging related conditions.
Parrish became the first recipient of dual gene therapy targeting biological aging in the year 2015. This achievement was the stepping stone to the new era in genetic medicine which also catalysed the founding of BioViva and positioning the company at the very top. Under Parrish’s leadership, the company has reached great heights in the field of anti aging therapeutics, having its pioneering research and visionary approach.
BioViva’s Approach to Defeat Aging
BioViva is at the forefront and is committed to completely revamp the treatment of biological aging. The company is trying to bridge the gap between successful animal studies and human patients and speed up the development of life saving gene therapies. With the help of collaborations and partnerships with assorted medical professionals, the company is dedicated to provide the best treatments possible.
A Committed Team Driving Progress
BioViva’s committed and expert team is led by none other than Elizabeth herself and they are mutually trying to embrace the unconventional perspectives and adopting an inclusive environment. BioViva has always encouraged innovative thinking in order to achieve mutual goals.
“Feedback is essential, we don’t look for my ideal perfection, we look for alignment on a goal and unique insight on how to reach it. The future is for everyone, all groups need to be represented,” says Parrish
The COVID – 19 Pandemic Crisis
“Crisper is great. The future of gene therapy looks bright.”
– Liz Parrish, CEO
Just like any other company that suffered from the pandemic, the medical industry too did, but more than others. In the times of the pandemic, BioViva prioritised safety by implementing remote work for their employees and operating its lab with a smaller group of staff members. Parrish recognises the importance of remote work in promoting work-life balance and improving customer service. By adapting to new challenges, BioViva continues to march towards advanced gene therapy and tackling aging.
“Treating aging has the potential to directly address the immune system and could reduce the risk of severe complications from infectious diseases,” stated LIz.
The Future of Healthcare
Looking at the growth of the healthcare industry, Parrish thoroughly believes that the healthcare industry has not yet matched the advances in medical technology. She also says that medicine will become more precise and personalised as patients will get access to more information about their own bodies and data analysis will make earlier diagnosis possible and therefore therapies will be more and more successful in the future. Liz concludes by saying, “We will move away from ‘sick care’ and towards preventive medicine.”
Magazine
